Grail Funding & Investors
GRAIL, Inc. operates as a biotechnology company. The Company focuses on combining science, technology, and clinical studies to reveal cancer at its beginings. GRAIL offers its services in the United States.
https://grail.comTotal Amount Raised: $2,004,654,976
Grail Funding Rounds
Series D
$390,000,000
Series D Investors
PSP InvestmentsCanada Pension Plan Investment Board (CPPIB)IlluminaHuangpu River CapitalSeries C
$300,000,000
Series C Investors
6 Dimensions CapitalAlly Bridge GroupHillhouse InvestmentHuangpu River CapitalICBC InternationalSequoia ChinaBlue Pool CapitalGenuity ScienceChina Merchants Securities Co.Series B
$1,214,655,040
Series B Investors
Arch Venture PartnersJohnson & Johnson DevelopmentGlen KacherAmino CapitalThe Mark Foundation for Cancer ResearchSeries A
$100,000,000
Series A Investors
IlluminaArch Venture PartnersBezos ExpeditionsBill GatesSutter Hill VenturesBiomatics Capital PartnersGVLongwood Fund
Funding info provided by Diffbot.